Study: Customers Will Spend More at Cleaner Restaurants

| Press Release
brochure cover
Successfully Monetizing Diagnostic Innovation

Diagnostics – a vital element of efficient healthcare provision.

| Perspective | Brochure | Healthcare & Life Sciences Diagnostics
Top Trends in Asia Wealth Management

New waves of digital disruption have been fueled by the COVID-19 pandemic.

| Blog | Financial Services Wealth & Asset Management Commercial Strategy & Pricing Consulting
digital healthcare
Digital Healthcare: How Life Sciences Companies can Leverage the “New Normal” in Digital Engagement

The COVID-19 crisis has accelerated the digital transformation in many industries – healthcare and Life Sciences being no exception.

| Blog | Healthcare & Life Sciences Digital Health & Health IT Commercial Strategy & Pricing Consulting
New Partners at Simon-Kucher: Resolving the Major Challenges Ahead for Life Sciences Companies

Simon-Kucher continues to grow, even during these challenging times.

| People & Stories
Ownership Models for Fashion Brands
Three Innovative Ownership Models for Fashion Brands

Consumer purchasing behavior is driving a shift toward a more sustainable economy, and the fashion industry is following suit.

| Blog | Consumer Fast-Moving Consumer Goods (FMCG) Retail Customer, Product & Market Strategy
girl in car laughing
How Upstart Carmakers Can Discover Their European Target Customers

How can international automotive companies convince potential customers to consider their brands?

| Blog | Automotive Commercial Strategy & Pricing Consulting
Beware the Dark Side of AI

Within the Biden administration’s first weeks, the Office of Science and Technology Policy has been elevated to a cabinet-level position.

| Press Release
Project Orbis: Implications for Access and Pricing in the UK

Post-Brexit, the UK’s MHRA is looking to join Project Orbis, a global program to speed up patient access to innovative cancer treatments.

| Press Release
NRDL China
Embracing the Change: Revisiting Simon-Kucher 2020 China NRDL Predictions

China’s 2020 NRDL (National Reimbursement Drug List) results are out, marking many firsts in history.

| Blog | Healthcare & Life Sciences Customer, Product & Market Strategy
Language
Search